Progress in unraveling the genetic etiology of Parkinson disease in a genomic era.
about
Current status of biomarker research in neurologyNeuroprotective Transcription Factors in Animal Models of Parkinson DiseaseThe Progress of Induced Pluripotent Stem Cells as Models of Parkinson's DiseaseGenetic Profile, Environmental Exposure, and Their Interaction in Parkinson's DiseaseDeconvoluting the complexity of autophagy and Parkinson's disease for potential therapeutic purposeMitochondrial Biology and Neurological DiseasesDiversity matters - heterogeneity of dopaminergic neurons in the ventral mesencephalon and its relation to Parkinson's DiseaseVPS35 regulates cell surface recycling and signaling of dopamine receptor D1Quantitative proteomic analysis of Parkin substrates in Drosophila neurons.Further evidence for the association of CYP2D6*4 gene polymorphism with Parkinson's disease: a case control studyGenome-Scale Networks Link Neurodegenerative Disease Genes to α-Synuclein through Specific Molecular Pathways.Precision medicine: Clarity for the clinical and biological complexity of Alzheimer's and Parkinson's diseases.Genetic variants in GAPDH confer susceptibility to sporadic Parkinson's disease in a Chinese Han population.Association of three candidate genetic variants in RAB7L1/NUCKS1, MCCC1 and STK39 with sporadic Parkinson's disease in Han Chinese.DNA methylation and cognitive aging.Telomere length in Parkinson's disease: A meta-analysisNeural ablation of the PARK10 candidate Plpp3 leads to dopaminergic transmission deficits without neurodegeneration.Nurr1-Based Therapies for Parkinson's Disease.Current Pharmaceutical Treatments and Alternative Therapies of Parkinson's Disease.Enrichment of risk SNPs in regulatory regions implicate diverse tissues in Parkinson's disease etiology.RAB39B gene mutations are not linked to familial Parkinson's disease in ChinaWhole-exome sequencing of 228 patients with sporadic Parkinson's diseaseParkinson's Disease: From Pathogenesis to PharmacogenomicsDissecting the role of Engrailed in adult dopaminergic neurons--Insights into Parkinson disease pathogenesisProteomics as an innovative tool to investigate frontotemporal disorders.The Role of Cathepsin D in the Pathogenesis of Human Neurodegenerative Disorders.DNA methylation in Parkinson's disease.Therapies for Parkinson's diseases: alternatives to current pharmacological interventions.Cutaneous malignant melanoma and Parkinson disease: Common pathways?AMPK in Neurodegenerative Diseases.Genetic Determinants of Parkinson's Disease: Can They Help to Stratify the Patients Based on the Underlying Molecular Defect?Systematic review on strength training in Parkinson's disease: an unsolved question.Association of four new candidate genetic variants with Parkinson's disease in a Han Chinese population.Base excision repair variants and pesticide exposure increase Parkinson's disease risk.Delaying aging is neuroprotective in Parkinson's disease: a genetic analysis in C. elegans models.Novel animal model defines genetic contributions for neuron-to-neuron transfer of α-synuclein.Effect of dental pulp stem cells in MPTP-induced old-aged mice model.Crosstalk between Lysosomes and Mitochondria in Parkinson's Disease.The yin and yang of α-synuclein-associated epigenetics in Parkinson's disease.Epigenetics in Parkinson's Disease.
P2860
Q26744505-022BD950-32C5-431C-9FDD-56CBBBF11F07Q26765693-369F8D54-9670-4E29-987F-F3F27132BFE1Q26765894-D0B42A2E-F24B-4F1C-9278-3B94CE8D7761Q26768278-4D0A198C-D7B6-478E-B5AC-1D692DBC6C85Q26785491-D14FF844-35AD-4A38-A7D4-5DD716192849Q28076942-6490886A-60F6-49C0-B2E7-45D22EF8B813Q28078561-5F343B20-6E3A-4059-8BCA-35587B43182DQ28117229-3389FB5D-799A-403B-81BC-86C9C6CB89FCQ30844860-6B454AEB-0ED3-491A-BEBB-2A42D57F5739Q33861662-C3D15B85-867B-4225-B335-517000A8DC12Q34550197-EA49C5BB-724E-4749-B5A3-F6931A4086DCQ35568431-5BE59529-D4C6-4A24-B31C-5C6096603802Q35741353-911853BD-926E-4A75-88D9-CA721355F591Q35935522-046C67A3-F858-488B-991C-87970DB834EFQ35987240-BF05C33E-FAEA-4EF9-BBE3-6B9F25CE1DAEQ36672712-4883A493-94DD-4CCE-9D48-E5C0F8D5DD1CQ36785175-0C7A3CC1-F9E1-4A48-ABBF-B1D8D3C9F187Q36803630-60B93891-1CF3-4CA3-B7D4-9BB448D06E26Q36925905-1BF70B5C-8483-45BA-88F7-A3CE1D4DF55FQ37129119-9E3161E9-B5E6-4C16-B178-C642F1548632Q37303405-332CA437-BA96-4C79-A237-16FE03E800B7Q37602056-EC3D0165-8AEE-477C-B5FC-8ED18B89F57AQ37729129-5A2E5A06-E2F3-47F4-ACB1-67C704340B51Q38605280-7F2723BE-9B38-43FD-A497-65EA4DC35E9BQ38802995-F4D0063C-ADB9-4F2A-A47C-242CD34BBDC3Q38817664-A6B9D16D-72AB-4303-B750-05C8BA297F2DQ38819038-A9BD790E-1429-4623-98D2-5488800EFB76Q38925121-33556A5B-62D9-4F7D-9501-73EE96700C99Q38985873-2BC64902-7CD3-4D34-A982-A59FED4C4E20Q38998405-E30DB58D-AC3F-4CD9-854E-EC247602DDDDQ39151939-8701C101-B909-4305-923E-9CAC5F0B95DDQ39241699-88D9417F-7FB2-468E-87A2-8B2A7CA7E0A8Q40201296-DA55E3E3-9591-497E-989D-59906DBC63E2Q40220255-6C7961B1-766C-4BAA-9E3C-2833F3513656Q41055590-0EEFF478-C4D7-4F84-BF9D-D529B3C5FB9DQ41311746-17535C63-5EBE-4DA4-9AE0-BE8C79445B9FQ46391470-26C10862-2853-4727-BE55-DAA882D09D5DQ47220079-BFC4B732-0007-46B7-9E37-826F4DDE8DD8Q47279155-2472B544-387F-4ADC-BF8E-B63B851C1168Q47320399-103EC494-718D-4F40-88FB-2F5D277FFA45
P2860
Progress in unraveling the genetic etiology of Parkinson disease in a genomic era.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Progress in unraveling the genetic etiology of Parkinson disease in a genomic era.
@en
type
label
Progress in unraveling the genetic etiology of Parkinson disease in a genomic era.
@en
prefLabel
Progress in unraveling the genetic etiology of Parkinson disease in a genomic era.
@en
P1433
P1476
Progress in unraveling the genetic etiology of Parkinson disease in a genomic era.
@en
P2093
Aline Verstraeten
Jessie Theuns
P304
P356
10.1016/J.TIG.2015.01.004
P577
2015-02-20T00:00:00Z